THIAZOLO[3,2-A]INDOLE-9-CARBOXYLIC ACID – (152812-49-2)

Piboserod, 152811-62-6, SB-207266, Piboserod [INN], N-[(1-butylpiperidin-4-yl)methyl]-3, 4-dihydro-2H-[1, 3]oxazino[3, 2-a]indole-10-carboxamide, Piboserod [INN:BAN], UNII-4UQ3S81B25, SB207256, 4UQ3S81B25, PIBOSEROD [MI], N-((1-butylpiperidin-4-yl)methyl)-3, 4-dihydro-2H-[1, 3]oxazino[3, 2-a]indole-10-carboxamide, PIBOSEROD [WHO-DD], SB 207266, DTXSID60165129, PIBOSEROD, 2H-(1, 3)OXAZINO(3, 2-A)INDOLE-10-CARBOXAMIDE, N-((1-BUTYL-4-PIPERIDINYL)METHYL)-3, 4-DIHYDRO-, SB 207266-A, SB 207256, N-[(1-BUTYLPIPERIDIN-4-YL)METHYL]-2H, 3H, 4H-[1, 3]OXAZINO[3, 2-A]INDOLE-10-CARBOXAMIDE, N-[(1-butyl-4-piperidinyl)methyl]-3, 4-dihydro-2H-[1, 3]-oxazino[3, 2-a]indole-10-carboxamide, 2H-(1, 3)OXAZINO(3, 2-A)INDOLE-10-CARBOXAMIDE, N-((1-BUTYL-4-PIPERIDINYL)METHYL)-3, 4-DIHYDRO-, N-((1-BUTYL-4-PIPERIDYL)METHYL)-3, 4-DIHYDRO-2H-(1, 3)OXAZINO(3, 2-A)INDOLE-10-CARBOXAMIDE, Serotonin 5-HT4 Receptor Antagonists, piboserodum, Piboserod?, N-((1-butylpiperidin-4-yl)methyl)-2H, 3H, 4H-(1, 3)oxazino(3, 2-a)indole-10-carboxamide, N-((1-butylpiperidin-4-yl)methyl)-3, 4-dihydro-2H-(1, 3)oxazino(3, 2-a)indole-10-carboxamide, MFCD00923681, BPMDOIC, GTPL225, SCHEMBL467339, CHEMBL356359, DTXCID8087620, BDBM85026, KVCSJPATKXABRQ-UHFFFAOYSA-N, BCP15982, EX-A1189, PDSP1_001702, PDSP2_001685, AKOS015909931, DB04873, FD10684, NCGC00250378-01, AC-36094, AS-82492, BP166459, HY-15574, NS00068599, Q75884, SB-207266, >=98% (HPLC), L000973, BRD-K02750403-001-01-4, BRD-K02750403-001-02-2, N-(1-Butylpiperidine-4-ylmethyl)-1, 2-(trimethyleneoxy)-1H-indole-3-carboxamide, N-((1-butyl-4-piperidinyl)methyl)-3, 4-dihydro-2H-(1, 3)oxazino(3, 2-a)indole-10-carboxamide, N-((1-Butyl-4-piperidyl)-methyl)-3, 4-dihydro-2H-(1, 3)oxazino(3, 2-a)indole-10-carboxamide, N-[(1-Butyl-4-piperidinyl)methyl]-3, 4-dihydro-2H-[1, 3]-oxazino[3, 2-alpha]indole-10-carboxamide, N-[(1-Butyl4-piperidinyl)methyl]-3, 4-dihydro-2H-[1, 3]-oxazino[3, 2-a]indole-10-carboxamide